Our study demonstrated that increased association of Drp1 with the mitochondria through binding to Fis1 in these AD models leads to excessive mitochondrial fragmentation and dysfunction and to cytotoxicity, as all these defects in the above AD models, including AD patient-derived fibroblasts, were suppressed by treatment with P110. Here, DNM1L is linked to Alzheimer disease.